Epstein - Barr virus latent membrane protein 1 suppresses reporter activity through modulation of promyelocytic leukemia protein-nuclear bodies

Virology Journal

Volumn 8, Issue , 2011, Pages

  Sides, Mark D ^a   Block, Gregory J ^b   Chadwick, Reid W ^a   Shan, Bin ^a   Flemington, Erik K ^a   Lasky, Joseph A ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

arsenic trioxide; Epstein Barr virus; Latent Membrane Protein 1; promyelocytic leukemia nuclear bodies; promyelocytic leukemia protein; reporter assay

Indexed keywords

ARSENIC TRIOXIDE; GELATINASE B; LATENT MEMBRANE PROTEIN 1; LUCIFERASE; PROMYELOCYTIC LEUKEMIA PROTEIN; SMALL INTERFERING RNA; BETA GALACTOSIDASE; EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; MATRIX PROTEIN; NUCLEAR PROTEIN; ORGANOARSENIC DERIVATIVE; OXIDE; PML PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL NUCLEUS INCLUSION BODY; CONTROLLED STUDY; DOSE RESPONSE; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GENE TARGETING; HUMAN; IMMUNOFLUORESCENCE MICROSCOPY; LEUKEMIA CELL LINE; NASOPHARYNX CARCINOMA; NONHUMAN; PLASMID; PROMYELOCYTIC LEUKEMIA; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM; VIRUS INHIBITION; VIRUS LATENCY; CELL LINE; DRUG ANTAGONISM; DRUG EFFECT; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETICS; METABOLISM; REPORTER GENE; VIROLOGY;

HUMAN HERPESVIRUS 4;

ARSENICALS; BETA-GALACTOSIDASE; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION REGULATION, LEUKEMIC; GENE EXPRESSION REGULATION, VIRAL; GENE SILENCING; GENES, REPORTER; HERPESVIRUS 4, HUMAN; HUMANS; INTRANUCLEAR INCLUSION BODIES; LEUKEMIA, PROMYELOCYTIC, ACUTE; LUCIFERASES; NUCLEAR PROTEINS; OXIDES; PLASMIDS; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS; VIRAL MATRIX PROTEINS;

EID: 80053519415     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-8-461     Document Type: Article

References (53)

1. Biochemical, genetic, and functional analyses of the phosphorylation sites on the Epstein-Barr virus-encoded oncogenic latent membrane protein LMP-1. Moorthy RK, Thorley-Lawson DA, J Virol 1993 67 2637 2645 8386269 (Pubitemid 23118860)
2. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator. Eliopoulos AG, Dawson CW, Mosialos G, Floettmann JE, Rowe M, Armitage RJ, Dawson J, Zapata JM, Kerr DJ, Wakelam MJ, et al. Oncogene 1996 13 2243 2254 8950992 (Pubitemid 26411575)
3. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis. Peng M, Lundgren E, Oncogene 1992 7 1775 1782 1354347
4. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Wang D, Liebowitz D, Kieff E, Cell 1985 43 831 840 10.1016/0092-8674(85)90256-9 3000618
5. Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus. Liebowitz D, Wang D, Kieff E, J Virol 1986 58 233 237 3005654 (Pubitemid 16021984)
6. Localization of the major NF-kappaB-activating site and the sole TRAF3 binding site of LMP-1 defines two distinct signaling motifs. Brodeur SR, Cheng G, Baltimore D, Thorley-Lawson DA, J Biol Chem 1997 272 19777 19784 10.1074/jbc.272.32.19777 9242637 (Pubitemid 27340070)
7. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E, Cell 1995 80 389 399 10.1016/0092-8674(95)90489-1 7859281
8. Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3. Sandberg M, Hammerschmidt W, Sugden B, J Virol 1997 71 4649 4656 9151858 (Pubitemid 27204157)
9. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production. Eliopoulos AG, Gallagher NJ, Blake SM, Dawson CW, Young LS, J Biol Chem 1999 274 16085 16096 10.1074/jbc.274.23.16085 10347160 (Pubitemid 29269312)
10. Epstein-Barr virus-encoded LMP1 regulates epithelial cell motility and invasion via the ERK-MAPK pathway. Dawson CW, Laverick L, Morris MA, Tramoutanis G, Young LS, J Virol 2008 82 3654 3664 10.1128/JVI.01888-07 18199641 (Pubitemid 351429941)
11. RECK is a target of Epstein-Barr virus latent membrane protein 1. Liu LT, Peng JP, Chang HC, Hung WC, Oncogene 2003 22 8263 8270 10.1038/sj.onc.1207157 14614450 (Pubitemid 37485519)
12. Activation of the JAK/STAT pathway in Epstein Barr virus+-associated posttransplant lymphoproliferative disease: role of interferon-gamma. Vaysberg M, Lambert SL, Krams SM, Martinez OM, Am J Transplant 2009 9 2292 2302 10.1111/j.1600-6143.2009.02781.x 19656130
13. Tumor-derived variants of Epstein-Barr virus latent membrane protein 1 induce sustained Erk activation and c-Fos. Vaysberg M, Hatton O, Lambert SL, Snow AL, Wong B, Krams SM, Martinez OM, J Biol Chem 2008 283 36573 36585 10.1074/jbc.M802968200 18986987
14. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2. Eliopoulos AG, Blake SM, Floettmann JE, Rowe M, Young LS, J Virol 1999 73 1023 1035 9882303 (Pubitemid 29036753)
15. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). Eliopoulos AG, Young LS, Oncogene 1998 16 1731 1742 10.1038/sj.onc.1201694 9582021 (Pubitemid 28175054)
16. A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus. Chen H, Hutt-Fletcher L, Cao L, Hayward SD, J Virol 2003 77 4139 4148 10.1128/JVI.77.7.4139-4148.2003 12634372 (Pubitemid 36350953)
17. Multiple signal transducers and activators of transcription are induced by EBV LMP-1. Zhang L, Hong K, Zhang J, Pagano JS, Virology 2004 323 141 152 10.1016/j.virol.2004.03.007 15165826 (Pubitemid 38681027)
18. Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein-Barr positive epithelial cells. Sides MD, Block GJ, Shan B, Esteves KC, Lin Z, Flemington EK, Lasky JA, Virology 2011 416 86 97 10.1016/j.virol.2011.04.005 21605886
19. Transcriptional regulation is affected by subnuclear targeting of reporter plasmids to PML nuclear bodies. Block GJ, Eskiw CH, Dellaire G, Bazett-Jones DP, Mol Cell Biol 2006 26 8814 8825 10.1128/MCB.00636-06 16966371 (Pubitemid 44851941)
20. Promyelocytic leukemia (PML) nuclear bodies are protein structures that do not accumulate RNA. Boisvert FM, Hendzel MJ, Bazett-Jones DP, J Cell Biol 2000 148 283 292 10.1083/jcb.148.2.283 10648561 (Pubitemid 30078240)
21. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body. Yeager TR, Neumann AA, Englezou A, Huschtscha LI, Noble JR, Reddel RR, Cancer Res 1999 59 4175 4179 10485449 (Pubitemid 29418720)
22. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Bernardi R, Pandolfi PP, Nat Rev Mol Cell Biol 2007 8 1006 1016 10.1038/nrm2277 17928811 (Pubitemid 350174636)
23. PML nuclear bodies. Lallemand-Breitenbach V, de The H, Cold Spring Harb Perspect Biol 2010 2 000661 10.1101/cshperspect.a000661 20452955
24. A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics. Van Damme E, Laukens K, Dang TH, Van Ostade X, Int J Biol Sci 2010 6 51 67 20087442
25. The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Lavau C, Marchio A, Fagioli M, Jansen J, Falini B, Lebon P, Grosveld F, Pandolfi PP, Pelicci PG, Dejean A, Oncogene 1995 11 871 876 7545807
26. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Stadler M, Chelbi-Alix MK, Koken MH, Venturini L, Lee C, Saib A, Quignon F, Pelicano L, Guillemin MC, Schindler C, et al. Oncogene 1995 11 2565 2573 8545113 (Pubitemid 26023824)
27. PML and PML nuclear bodies: implications in antiviral defence. Everett RD, Chelbi-Alix MK, Biochimie 2007 89 819 830 10.1016/j.biochi.2007.01.004 17343971 (Pubitemid 47008945)
28. The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. Maul GG, Everett RD, J Gen Virol 1994 75 Pt 6 1223 1233 8207389 (Pubitemid 24174037)
29. Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). Maul GG, Guldner HH, Spivack JG, J Gen Virol 1993 74 Pt 12 2679 2690 8277273 (Pubitemid 24020661)
30. HSV-1 IE protein Vmw110 causes redistribution of PML. Everett RD, Maul GG, EMBO J 1994 13 5062 5069 7957072 (Pubitemid 24341087)
31. Disruption of PML-associated nuclear bodies during human cytomegalovirus infection. Kelly C, Van Driel R, Wilkinson GW, J Gen Virol 1995 76 Pt 11 2887 2893 7595400
32. Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies. Adamson AL, Kenney S, J Virol 2001 75 2388 2399 10.1128/JVI.75.5.2388-2399.2001 11160742 (Pubitemid 32147577)
33. Firefly luciferase gene: structure and expression in mammalian cells. de Wet JR, Wood KV, DeLuca M, Helinski DR, Subramani S, Mol Cell Biol 1987 7 725 737 3821727 (Pubitemid 17004537)
34. Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. Brasier AR, Tate JE, Habener JF, Biotechniques 1989 7 1116 1122 2698191 (Pubitemid 20022349)
35. The Epstein-Barr virus oncoprotein LMP1 inhibits the activity of viral or cellular promoters without inducing cytostasis. Narbonnet S, Mariame B, Virology 2006 350 381 393 10.1016/j.virol.2006.02.010 16533516 (Pubitemid 43928108)
36. Latent membrane protein 1 of Epstein-Barr virus inhibits as well as stimulates gene expression. Sandberg ML, Kaykas A, Sugden B, J Virol 2000 74 9755 9761 10.1128/JVI.74.20.9755-9761.2000 11000250
37. The Epstein-Barr Virus LMP 1 and TGF-{beta}1 Synergistically Induce EMT in Lung Epithelial Cells. Sides MD, Klingsberg RC, Shan B, Gordon KA, Nguyen HT, Lin Z, Takahashi T, Flemington EK, Lasky JA, Am J Respir Cell Mol Biol 2010
38. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML. Zhang XW, Yan XJ, Zhou ZR, Yang FF, Wu ZY, Sun HB, Liang WX, Song AX, Lallemand-Breitenbach V, Jeanne M, et al. Science 2010 328 240 243 10.1126/science.1183424 20378816
39. Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Lallemand-Breitenbach V, Jeanne M, Benhenda S, Nasr R, Lei M, Peres L, Zhou J, Zhu J, Raught B, de The H, Nat Cell Biol 2008 10 547 555 10.1038/ncb1717 18408733 (Pubitemid 351627374)
40. Arsenic trioxide stimulates SUMO-2/3 modification leading to RNF4-dependent proteolytic targeting of PML. Weisshaar SR, Keusekotten K, Krause A, Horst C, Springer HM, Gottsche K, Dohmen RJ, Praefcke GJ, FEBS Lett 2008 582 3174 3178 10.1016/j.febslet.2008.08.008 18708055
41. Regulation of matrix metalloproteinase gene expression. Yan C, Boyd DD, J Cell Physiol 2007 211 19 26 10.1002/jcp.20948 17167774 (Pubitemid 46363892)
42. LMP1 structure and signal transduction. Eliopoulos AG, Young LS, Semin Cancer Biol 2001 11 435 444 10.1006/scbi.2001.0410 11669605 (Pubitemid 33105022)
43. Up-regulation of beta-catenin by a viral oncogene correlates with inhibition of the seven in absentia homolog 1 in B lymphoma cells. Jang KL, Shackelford J, Seo SY, Pagano JS, Proc Natl Acad Sci USA 2005 102 18431 18436 10.1073/pnas.0504054102 16344472 (Pubitemid 43011243)
44. Epstein-Barr virus-encoded latent membrane protein 1 activates beta-catenin signaling in B lymphocytes. Tomita M, Dewan MZ, Yamamoto N, Kikuchi A, Mori N, Cancer Sci 2009 100 807 812 10.1111/j.1349-7006.2009.01121.x 19309363
45. Epstein-Barr virus associated modulation of Wnt pathway is not dependent on latent membrane protein-1. Webb N, Connolly G, Tellam J, Yap AS, Khanna R, PLoS One 2008 3 3254 10.1371/journal.pone.0003254 18806872
46. Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB. Mori N, Morishita M, Tsukazaki T, Yamamoto N, Int J Cancer 2003 105 661 668 10.1002/ijc.11146 12740915 (Pubitemid 36687734)
47. Inhibition of transforming growth factor beta signaling and Smad-dependent activation of transcription by the Latent Membrane Protein 1 of Epstein-Barr virus. Prokova V, Mosialos G, Kardassis D, J Biol Chem 2002 277 9342 9350 10.1074/jbc.M109099200 11781310 (Pubitemid 34953018)
48. Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth. Kim KR, Yoshizaki T, Miyamori H, Hasegawa K, Horikawa T, Furukawa M, Harada S, Seiki M, Sato H, Oncogene 2000 19 1764 1771 10.1038/sj.onc.1203502 10777210 (Pubitemid 30200982)
49. Establishment of an Epithelioid Cell Line and a Fusiform Cell Line from a Patient with Nasopharyngeal Carcinoma. LTVCI, Sci Sinica 1978 21 127 206962
50. Epstein-Barr virus latent membrane protein 1 induces cellular MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. Cameron JE, Yin Q, Fewell C, Lacey M, McBride J, Wang X, Lin Z, Schaefer BC, Flemington EK, J Virol 2008 82 1946 1958 10.1128/JVI.02136-07 18057241 (Pubitemid 351206940)
51. Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY, Ballard DW, Mol Cell Biol 1995 15 2809 2818 7739562
52. Expression cloning identifies transgelin (SM22) as a novel repressor of 92-kDa type IV collagenase (MMP-9) expression. Nair RR, Solway J, Boyd DD, J Biol Chem 2006 281 26424 26436 10.1074/jbc.M602703200 16835221 (Pubitemid 44401851)
53. Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements. Veeman MT, Slusarski DC, Kaykas A, Louie SH, Moon RT, Curr Biol 2003 13 680 685 10.1016/S0960-9822(03)00240-9 12699626 (Pubitemid 36453318)